Designer cytokine may be the next treatment for T2D

Australian researchers say they have developed a designer cytokine  – IC7Fc  – that promises to have multiple actions to treat type 2 diabetes. The novel molecule IC7Fc combines the effects of  interleukin-6 (IL-6) and ciliary neurotrophic factor (CNTF) to improve glucose tolerance and hyperglycaemia and prevent weight gain and liver steatosis, according to Professor Mark Febbraio, ...

Already a member?

Login to keep reading.

© 2021 the limbic